News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences (Foster City, CA) (GILD) Completes Acquisition Of Corus Pharma, Inc.


8/14/2006 10:56:31 AM

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it has completed its acquisition of Corus Pharma. Gilead also announced that the company has received regulatory clearance by the United States Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Gilead will provide updated full year 2006 expense guidance reflecting the impact of the Corus acquisition on the company's third quarter 2006 earnings conference call on October 18, 2006.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES